Why the study?
Exposure therapy for anxiety and related disorders has high dropout rates predicted by lower resting heart rate variability, motivating biofeedback integration to potentially improve outcomes.
Does incorporating biofeedback into exposure therapy improve patient outcomes and experience in patients with anxiety and related disorders?
Does incorporating biofeedback into exposure therapy improve patient outcomes and experience in patients with anxiety and related disorders?
Answers are grounded in this paper and cite their sources.
Incorporating respiration and heart rate variability biofeedback into exposure therapy has the potential to improve patient outcomes and reduce dropout rates in anxiety disorders.
Exposure therapy is an evidence-based psychotherapeutic technique for anxiety and related disorders. However, the dropout rate ranges from 10%–30%, and poor outcomes such as dropout are predicted by lower resting heart rate variability (HRV), which, in turn, predicts neural correlates of anxiety. Incorporating biofeedback into traditional exposure therapy has the potential to improve patient outcomes and experience through two protocols: (a) framing respiration and HRV biofeedback as a preparatory intervention for exposure therapy and (b) integrating selected biofeedback modalities into traditional exposure therapy sessions.
No takes yet. Share an insight, caveat, or question.
Nate L. Ewigman (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: